MedPath

Medifend Nevmax Capsule

Registration Number: MAL23066075NC

Approved
Approval ID

6152a69ae0fbafeb

Registration Number

MAL23066075NC

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types7 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (7)

10 CapsulesAvailable
Package Size: 10 Capsules
Status: NPRA Approved
20 CapsulesAvailable
Package Size: 20 Capsules
Status: NPRA Approved
30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (6)

Pyrroloquinoline quinone disodium saltActive
Monograph: pyrroloquinoline quinone disodium salt
BENFOTIAMINEActive
Monograph: 苯磷硫胺
SODIUM LIPOATEActive
Monograph: sodium lipoate
PYRIDOXINE HYDROCHLORIDEActive
Monograph: 维生素B6
(6S)-5-Methyltetrahydrofolic acid, glucosamine saltActive
Monograph: (6 s)-5-methyltetrahydrofolic acid, glucosamine salt
METHYLCOBALAMINActive
Monograph: 甲钴胺

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Medifend Nevmax Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform